In the News
Dec. 1, 2011: In Vivo 2011 Nominee Exit/Financing Deal of the Year: BMS/Amira. Excerpt: Versant Ventures, one of the firms that cashed out in the sale, drew up a whole new investment model designed to avoid Amira’s complications – and hired Amira’s chief scientist, Peppi Prasit, to get it off the ground, formally establishing three new companies in the process. Versant first established Inception Sciences, a drug discovery “mothership” that will spin out asset-focused companies to house drug candidates as they reach maturity; the firm also invested $5 million apiece in Inception I and II, the first two LLCs that will shepherd those assets along.
Nov. 29, 2011: Fresh Off Amira Success, Versant’s Bolzon and San Diego’s Prasit Begin Anew with Inception. See Xconomy.com.
July 27, 2011: Versant Supports Biotech Incubator From Amira Co-Founder. See Venture Capital Dispatch for full article
Full website under construction
|
Contact Us
Inception Sciences, Inc
5871 Oberlin Drive, Suite 100
San Diego, CA 92121
Phone: 858 224.7700
Fax: 858 558.5732
Inquiries
Cathy Stuhler
CStuhler@inceptionsci.com
Phone: 858 224.7701
Click map for directions:
|
